Bionano Genomics, Inc. (BNGO)

Add to research

Evaluation: Based on all recent filings, financial statements, and news.

See full evaluation
Company performance
Add to research
View more

Current Price

as of Jun 13, 2025

$3.65

P/E Ratio

N/A

Market Cap

$12.28M

Description
Add to research
View more

Bionano Genomics, Inc. is a life sciences instrumentation company, which focuses on the genome analysis space. The firm engages in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline cytogenetics. Its products include Saphyr, Bionano Chips, Bionano Prep Kits, and Bionano Data Solutions. The company was founded by Han Cao in January 2003 and is headquartered in San Diego, CA.

Metrics
Add to research
View more

Overview

  • HQSan Diego, CA
  • SectorHealth Technology
  • IndustryBiotechnology
  • TickerBNGO
  • Price$3.65-1.35%

Trading Information

  • Market cap$12.28M
  • Float99.64%
  • Average Daily Volume (1m)70,345
  • Average Daily Volume (3m)136,675
  • EPS-$57.26

Company

  • Revenue$28.46M
  • Rev growth (1yr)-26.37%
  • Net income-$3.10M
  • Gross margin45.50%
  • EBITDA margin-92.61%
  • EBITDA-$5.98M
  • EV-$3.30M
  • EV/Revenue-0.12
  • P/EN/A
  • P/S0.35
  • P/B0.23
  • Debt/Equity38.21
Documents
Add to research
View more